Dyne Therapeutics, Inc.
Total Trades
132
Buys
3
Sells
105
Largest Trade
N/A
Insiders
14
Institutional Funds
173
Inst. Value
$1M+
Activist Filings
49
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Scalzo Richard William | SVP | SELL | $50K–$100K | 3K | $30.74 | Jun 11, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $1M+ | 30K | $32.96 | May 23, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | EXERCISE | $15K–$50K | 30K | $1.03 | May 23, 2024 |
| Brumm Joshua T | CEO & President | SELL | $1M+ | 100K | $28.96 | Mar 2, 2024 |
| Brumm Joshua T | CEO & President | EXERCISE | $500K+ | 100K | $5.54 | Mar 2, 2024 |
| McNeill Jonathan | Chief Business Off… | SELL | $500K+ | 29K | $28.46 | Mar 2, 2024 |
| McNeill Jonathan | Chief Business Off… | EXERCISE | $15K–$50K | 29K | $0.73 | Mar 2, 2024 |
| Scalzo Richard William | SVP | SELL | $100K–$500K | 13K | $28.05 | Mar 2, 2024 |
| Scalzo Richard William | SVP | EXERCISE | $1K–$15K | 13K | $1.03 | Mar 2, 2024 |
| Rhodes Jason P | Director | SELL | $1M+ | 808K | $24.30 | Feb 29, 2024 |
| Atlas Venture Fund XI, L.P. | 10% Owner | SELL | $1M+ | 808K | $24.30 | Feb 29, 2024 |
| Farwell Wildon | Chief Medical Offi… | SELL | $1K–$15K | 407 | $25.00 | Feb 28, 2024 |
| Rhodes Jason P | Director | SELL | $1M+ | 501K | $22.64 | Feb 23, 2024 |
| Atlas Venture Fund XI, L.P. | 10% Owner | SELL | $1M+ | 501K | $22.64 | Feb 23, 2024 |
| Rhodes Jason P | Director | SELL | $1M+ | 510K | $23.26 | Feb 20, 2024 |
| Atlas Venture Fund XI, L.P. | 10% Owner | SELL | $1M+ | 510K | $23.26 | Feb 20, 2024 |
| Farwell Wildon | Chief Medical Offi… | SELL | $100K–$500K | 5K | $25.07 | Feb 14, 2024 |
| Farwell Wildon | Chief Medical Offi… | SELL | $1K–$15K | 100 | $25.00 | Jan 27, 2024 |
| McNeill Jonathan | Chief Business Off… | SELL | $100K–$500K | 20K | $24.53 | Jan 27, 2024 |
| McNeill Jonathan | Chief Business Off… | EXERCISE | $1K–$15K | 20K | $0.73 | Jan 27, 2024 |
| Scalzo Richard William | SVP | EXERCISE | $1K–$15K | 13K | $1.03 | Jan 27, 2024 |
| Scalzo Richard William | SVP | SELL | $100K–$500K | 13K | $24.34 | Jan 27, 2024 |
| Brumm Joshua T | CEO & President | SELL | $1M+ | 270K | $18.66 | Jan 5, 2024 |
| Brumm Joshua T | CEO & President | EXERCISE | $1M+ | 270K | $4.37 | Jan 5, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | EXERCISE | $50K–$100K | 68K | $1.03 | Jan 5, 2024 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $1M+ | 88K | $18.57 | Jan 5, 2024 |
| McNeill Jonathan | Chief Business Off… | SELL | $500K+ | 32K | $16.59 | Jan 5, 2024 |
| McNeill Jonathan | Chief Business Off… | EXERCISE | $1K–$15K | 20K | $0.73 | Jan 5, 2024 |
| Scalzo Richard William | SVP | EXERCISE | $1K–$15K | 13K | $1.03 | Jan 5, 2024 |
| Scalzo Richard William | SVP | SELL | $100K–$500K | 13K | $18.81 | Jan 5, 2024 |
| HIGH SUSANNA GATTI | COO | SELL | $50K–$100K | 10K | $7.40 | Nov 2, 2023 |
| Scalzo Richard William | See Remarks | SELL | $1K–$15K | 1K | $9.41 | Sep 20, 2023 |
| McNeill Jonathan | Chief Business Off… | SELL | $1K–$15K | 1K | $9.41 | Sep 20, 2023 |
| HIGH SUSANNA GATTI | COO | SELL | $15K–$50K | 3K | $9.41 | Sep 20, 2023 |
| Brumm Joshua T | See Remarks | SELL | $100K–$500K | 12K | $9.41 | Sep 20, 2023 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $1K–$15K | 1K | $9.41 | Sep 20, 2023 |
| Farwell Wildon | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.41 | Sep 13, 2023 |
| Scalzo Richard William | See Remarks | SELL | $1K–$15K | 1K | $10.41 | Sep 13, 2023 |
| McNeill Jonathan | Chief Business Off… | SELL | $1K–$15K | 1K | $10.41 | Sep 13, 2023 |
| HIGH SUSANNA GATTI | COO | SELL | $15K–$50K | 2K | $10.41 | Sep 13, 2023 |
| Brumm Joshua T | See Remarks | SELL | $50K–$100K | 8K | $10.41 | Sep 13, 2023 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $15K–$50K | 1K | $10.41 | Sep 13, 2023 |
| Scalzo Richard William | See Remarks | SELL | $500K+ | 51K | $12.71 | Jun 15, 2023 |
| Scalzo Richard William | See Remarks | EXERCISE | $15K–$50K | 40K | $1.03 | Jun 15, 2023 |
| McNeill Jonathan | See Remarks | SELL | $15K–$50K | 2K | $12.68 | Jun 14, 2023 |
| HIGH SUSANNA GATTI | COO | SELL | $15K–$50K | 2K | $12.43 | Jun 14, 2023 |
| Farwell Wildon | Chief Medical Offi… | SELL | $15K–$50K | 2K | $12.43 | Jun 14, 2023 |
| Beskrovnaya Oxana | Chief Scientific O… | SELL | $15K–$50K | 1K | $12.43 | Jun 14, 2023 |
| Brumm Joshua T | See Remarks | SELL | $1M+ | 325K | $12.90 | Jun 13, 2023 |
| Brumm Joshua T | See Remarks | EXERCISE | $100K–$500K | 278K | $1.03 | Jun 13, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 173 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 9.1M | $1M+ | SH |
| STATE STREET CORP | 6.7M | $1M+ | SH |
| Siren, L.L.C. | 3.5M | $1M+ | SH |
| PERCEPTIVE ADVISORS LLC | 3.5M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 3.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8M | $1M+ | SH |
| Deep Track Capital, LP | 2.6M | $1M+ | SH |
| Vivo Capital, LLC | 2.6M | $1M+ | SH |
| Sofinnova Investments, Inc. | 2.3M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 2.2M | $1M+ | SH |
| VR Adviser, LLC | 2.2M | $1M+ | SH |
| BRAIDWELL LP | 1.5M | $1M+ | SH |
| Palo Alto Investors LP | 1.5M | $1M+ | SH |
| MPM BioImpact LLC | 1.4M | $1M+ | SH |
| Logos Global Management LP | 1.3M | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $1M+ | SH |
| Aberdeen Group plc | 1.1M | $1M+ | SH |
| Candriam S.C.A. | 1.1M | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 701K | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 680K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
T. Rowe Price Investment Management, Inc.
SC 13G/A · Mar 6, 2026
16.2%
26.6M shares
SC 13G/A · Feb 17, 2026
8.5%
13.9M shares
T. Rowe Price Investment Management, Inc.
SC 13G · Jan 8, 2026
10.7%
17.5M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Nov 14, 2025
10.4%
14.7M shares
SC 13G/A · Nov 13, 2025
4.0%
5.7M shares
SC 13G/A · Aug 7, 2025
10.1%
14.4M shares
SC 13G/A · May 15, 2025
8.5%
9.7M shares
Point72 Asset Management, L.P.
SC 13G/A · May 15, 2025
1.5%
1.7M shares
SC 13G/A · May 15, 2025
4.8%
5.4M shares
SC 13G/A · May 15, 2025
1.5%
1.7M shares
SC 13G/A · May 14, 2025
9.2%
10.4M shares
SC 13G/A · May 12, 2025
4.6%
5.2M shares
SC 13G/A · Apr 17, 2025
5.8%
6.6M shares
SC 13G/A · Feb 14, 2025
7.3%
7.4M shares
SC 13G/A · Feb 14, 2025
5.1%
5.2M shares
SC 13G/A · Feb 12, 2025
7.9%
8.0M shares
Point72 Asset Management, L.P.
SC 13G · Feb 3, 2025
5.1%
5.2M shares
SC 13G/A · Nov 14, 2024
6.4%
6.4M shares
SC 13G/A · Nov 14, 2024
5.7%
5.7M shares
SC 13G/A · Nov 14, 2024
2.9%
6 shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Nov 14, 2024
6.8%
6.8M shares
SC 13G/A · Nov 14, 2024
3.3%
3.3M shares
SC 13G/A · Nov 14, 2024
5.8%
5.8M shares
SC 13G · Nov 14, 2024
6.8%
6.8M shares
SC 13G/A · Nov 12, 2024
6.8%
6.9M shares
SC 13G · Nov 12, 2024
9.0%
9.0M shares
SC 13G/A · Nov 8, 2024
7.8%
7.8M shares
SC 13G/A · Nov 4, 2024
6.8%
6.9M shares
SC 13G/A · Oct 22, 2024
7.8%
7.8M shares
SC 13G · Apr 4, 2024
6.4%
5.2M shares
SC 13G/A · Feb 14, 2024
5.0%
6 shares
SC 13G/A · Feb 14, 2024
3.3%
2.0M shares
SC 13G/A · Feb 12, 2024
4.0%
3.2M shares
SC 13G · Jan 29, 2024
6.2%
3.8M shares
SC 13G · Jan 19, 2024
5.5%
4.5M shares
SC 13G/A · Jan 19, 2024
3.3%
2.0M shares
SC 13G/A · Feb 14, 2023
14.1%
7.3M shares
SC 13G/A · Feb 14, 2023
4.1%
2.1M shares
SC 13G/A · Feb 14, 2023
5.2%
2.7M shares
SC 13G/A · Feb 14, 2023
5.6%
6 shares
SC 13D/A · Feb 10, 2023
4.2%
2.2M shares
SC 13G/A · Feb 9, 2023
8.9%
4.6M shares
SC 13G/A · Nov 14, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
5.4%
2.8M shares
SC 13G/A · Feb 14, 2022
5.7%
3.0M shares
SC 13G/A · Feb 14, 2022
5.5%
6 shares
SC 13G/A · Feb 11, 2022
14.2%
7.3M shares
SC 13G · Jan 20, 2022
5.5%
2.8M shares